A lower abundance of butyrate-producing bacteria has been reiteratively described in several studies in CRC patients, and the administration of Butyricicoccus pullicaecorum to dimethylhydrazine-treated mice improved the clinical outcome of CRC through the activation of GPR45 and MCT1 expression [106]. The gene discussed is SLC16A1; the disease is colorectal carcinoma.